Novarus Discoveries Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2018
- Revenue 3.69%
(FY 2016)
- Profit 2.55%
(FY 2016)
- Net Worth 84.87%
(FY 2016)
- Total Assets -2.34%
(FY 2016)
About Novarus Discoveries
The Corporate was formerly known as Hemarus Pharmaceuticals Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dr Chigurupati, Padmasree Chigurupati, and Chotu Harabla serve as directors at the Company.
- CIN/LLPIN
U24100TG2011PTC074026
- Company No.
074026
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 2011
- Date of AGM
30 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Novarus Discoveries?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chotu Harabla  | Additional Director | 31-Jan-2019 | Current |
Dr Chigurupati  | Director | 21-Apr-2011 | Current |
| Padmasree Chigurupati | Director | 21-Apr-2011 | Current |
Financial Performance and Corporate Structure Insights of Novarus Discoveries.
Novarus Discoveries Private Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 3.69% increase. The company also saw a slight improvement in profitability, with a 2.55% increase in profit. The company's net worth Soared by an impressive increase of 84.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Novarus Discoveries?
In 2016, Novarus Discoveries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chigurupati Saisriram Enterprises Private LimitedActive 12 years 6 monthsDr Chigurupati and Padmasree Chigurupati are mutual person
- Narayana Infra Projects India LimitedActive 32 years 5 months
Padmasree Chigurupati is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Novarus Discoveries?
Unlock and access historical data on people associated with Novarus Discoveries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novarus Discoveries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novarus Discoveries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
